Elise C Hoover

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 3

Top Topics

Epithelial Mesenchymal Transition

Toll Like Receptor

Top Venues

Molecular pharmaceutics

This page only lists publications with an associated author ORCID identifier.

Publications

Elise C Hoover, Olivia M Ruggiero, Rachel N Swingler, Emily S Day
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. ACS omega 9 (12) (2024)
Elise C Hoover, Olivia M Ruggiero, Rachel N Swingler, Emily S Day
FZD7-Targeted Nanoparticles to Enhance Doxorubicin Treatment of Triple-Negative Breast Cancer. ACS omega 9 (12) (2024)
Mackenzie A Scully, Dana E Wilkins, Megan N Dang, Elise C Hoover, Sara B Aboeleneen, Emily S Day
Cancer Cell Membrane Wrapped Nanoparticles for the Delivery of a Bcl-2 Inhibitor to Triple-Negative Breast Cancer. Molecular pharmaceutics (2023)